跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Prevaclav 625 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Prevaclav 625
Approved
STANDARD
Prevaclav 625
Sun Pharmaceutical Industries Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e991cea31b99c8d8
Company
Sun Pharmaceutical Industries Limited
Type
Standard
Approval Details
Approval Id
e991cea31b99c8d8
Drug Approval Philippines Name
Prevaclav 625
Product Name
Prevaclav 625
Registration Number
DRP-1324-04
Brand Name
Prevaclav 625
Generic Name
Co-Amoxiclav
Dosage Form
Film-Coated Tablet
Dosage Strength
625 mg
Manufacturer
Sun Pharmaceutical Industries Limited
Importer
Sun Pharma Philippines, Inc.
Distributor
Preventia Healthcare Inc.
Company Detail Path
/organization/sun-pharmaceutical-industries-limited
Issuance Date
24 June 2022
Expiry Date
17 June 2027
Pharmacologic Category
Antibacterial (Penicillin/Beta-Lactamase Inhibitor Combination)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e991cea31b99c8d8
Type
Standard
Back to Philippines FDA Approvals